Abeona Therapeutics Cash Flow Statement (2010-2025) | ABEO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-16.00M	-15.21M	-15.54M	-46.67M	-20.79M	-8.18M	-9.54M	-13.11M	-12.14M	-10.66M	-11.44M	-13.32M	-15.28M	7.41M	-30.27M	-9.29M	-20.73M	124.34M	-5.16M	-20.46M
Depreciation and Depletion (Quarter)					0.80M				0.70M
Share-based Compensation (Quarter)	1.95M	2.43M	2.54M	2.00M	0.86M	0.72M	0.63M	0.83M	0.77M	0.93M	1.56M	1.51M	1.55M	1.32M	1.80M	1.96M	2.70M	2.83M	2.69M	2.56M
Gains from Sales and Divestitures (Quarter)								0.03M				0.27M	0.04M	0.82M	0.97M	1.01M	0.07M	0.50M	1.40M	1.46M
Gains from Investment Securities (Quarter)	0.02M	0.00M	0.00M	-0.02M	-0.15M	-4.20M	-3.05M	5.86M	0.01M	8.63M	1.10M	0.32M	0.01M	-24.93M	0.00M		-7.25M	0.18M	-2.76M	0.24M
Asset Writedowns and Impairment (Quarter)					1.35M	0.21M	0.04M	0.19M
Non-cash Items (Quarter)												0.00M	0.14M	0.15M	0.16M	0.01M	0.00M	0.01M	0.17M	0.01M
Cash from Operations (Quarter)	-13.59M	-11.49M	-10.33M	-30.26M	-13.69M	-9.01M	-6.79M	-13.99M	-11.74M	-10.28M	-5.75M	-9.23M	-14.54M	-12.68M	-12.23M	-16.56M	-18.40M	-18.78M	-21.19M	-17.95M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.27M	-0.53M	0.01M	0.13M	0.08M	0.81M	0.30M	-0.82M	0.12M	-0.04M	-0.21M	0.23M	0.23M	-0.17M	0.60M	0.24M	-0.46M	0.96M	-0.71M	1.22M
Depreciation & Amortization (CF) (Quarter)	0.82M	0.02M	0.80M	0.81M	0.81M	0.77M	0.78M	0.73M	0.66M	0.61M	0.52M	0.49M	0.49M	0.49M	0.49M	0.54M	0.53M	0.54M	0.61M	0.86M
Change in Working Capital
Change in Receivables (Quarter)					-3.00M	1.00M	3.05M	-0.86M	0.07M	3.42M	-1.48M	0.02M	-0.25M	-0.55M	-0.03M	0.04M	-0.04M	0.01M	-0.01M	-1.05M
Change in Inventory (Quarter)																			2.16M	0.64M
Change in Account Payables (Quarter)	1.42M	1.50M	0.67M	-20.00M	-0.30M
Change in Accured Expenses (Quarter)	-3.02M	-1.95M	0.52M	5.28M	-4.39M	0.70M	-1.44M	1.02M	0.00M		0.76M	1.28M	-1.69M	1.57M	-0.08M	1.71M	0.11M	1.19M	-1.36M	-0.02M
Change in Taxes (Quarter)																			-15.17M	-0.21M
Investing Activities
Capital Expenditures (Quarter)	0.44M	0.06M	0.40M	3.25M	0.10M		0.00M	0.03M	0.22M	0.03M	0.04M	0.04M	0.72M	0.71M	-1.27M	2.28M	1.40M	-0.04M	-1.06M	7.67M
Sales of Property, Plant and Equipment (Quarter)							0.10M	0.14M			0.01M	0.02M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)	24.98M	21.98M	27.16M	16.25M	8.66M	24.07M	10.97M	8.94M	10.39M	11.26M	15.36M	14.97M	22.25M	17.11M	50.87M	29.96M	54.26M	98.11M
Cash from Investing Activities (Quarter)	9.38M	21.92M	26.76M	8.00M	1.07M	-1.40M	1.65M	-25.29M	2.21M	5.21M	-18.74M	11.53M	-7.82M	-44.13M	-6.17M	18.88M	4.21M	155.89M	-64.63M	9.55M
Financing Activities
Other financing activities (Quarter)													0.96M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)													20.00M
Short-Term Debt issuances (Quarter)
Short-Term Debt repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	5.21M	2.46M	-6.83M	7.22M				28.41M			16.36M	-8.57M	6.42M	63.74M	-60.19M	5.51M	6.80M	10.50M		3.60M
Dividend Payments
Dividends Paid - Preferred (Quarter)
Misc.
Cash from Financing Activities (Quarter)	5.88M	2.48M	0.17M	16.33M			4.19M	42.77M	-0.00M	6.62M	22.98M	7.47M	25.44M	73.68M	-0.30M	5.31M	6.77M	10.49M	5.16M	3.61M
Change in Cash (Quarter)	1.67M	12.91M	16.60M	-5.93M	-12.61M	-14.19M	-0.95M	3.48M	-9.54M	1.54M	-1.51M	9.76M	3.08M	16.87M	-18.70M	7.63M	-7.42M	147.60M	-80.65M	-4.79M
Free Cash Flow (Quarter)	-14.03M	-11.55M	-10.74M	-33.51M	-13.79M	-9.01M	-6.79M	-14.02M	-11.96M	-10.32M	-5.79M	-9.27M	-15.26M	-13.39M	-10.96M	-18.84M	-19.80M	-18.75M	-20.12M	-25.63M
Net Cash Flow (Quarter)	1.67M	12.91M	16.60M	-5.93M	-12.61M	-10.41M	-0.95M	3.48M	-9.54M	1.54M	-1.51M	9.76M	3.08M	16.87M	-18.70M	7.63M	-7.42M	147.60M	-80.65M	-4.79M

Research Tools

Abeona Therapeutics Cash Flow Statement (2010-2025) | ABEO

Create an account

Sign In

Reset Password